Safety and efficacy of aspirin after combined cerebral revascularization for ischemic moyamoya disease: A prospective study

OBJECTIVE: To analyze the safety and efficacy of regular aspirin use after combined cerebral revascularization in patients with ischemic moyamoya disease. METHODS: From December 2020 to October 2021, a total of 326 patients diagnosed with ischemic moyamoya disease by global cerebral angiography and...

Descripción completa

Detalles Bibliográficos
Autores principales: Xue, Bingqian, Zhang, Shao, Guo, Gaochao, Wu, Ruiyu, Gu, Kaiwen, Zhao, Liming, Li, Chaoyue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Surgery
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10246502/
https://www.ncbi.nlm.nih.gov/pubmed/37292489
http://dx.doi.org/10.3389/fsurg.2023.1091062

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10246502/
https://www.ncbi.nlm.nih.gov/pubmed/37292489
http://dx.doi.org/10.3389/fsurg.2023.1091062

Ejemplares similares